Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes JOURNAL OF NEUROENDOCRINOLOGY 2023
Gastrinomas and non-functioning pancreatic endocrine tumors in multiple endocrine neoplasia syndrome type-1 (MEN-1) ENDOCRINE 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? FRONTIERS IN ENDOCRINOLOGY 2023
Long-acting somatostatin analogs and well differentiated neuroendocrine tumors: a 20-year-old story JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors GENES 2023
The Impact of Non-Andrological Medications on Semen Characteristics, Oxidative Stress and Inflammatory Parameters MEDICINA 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? ENDOCRINE 2023
Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays MINERVA ENDOCRINOLOGY 2023
Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials? FRONTIERS IN ENDOCRINOLOGY 2023
Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome ENDOCRINE 2023
Gender-related differences in patients with carcinoid syndrome: new insights from an Italian multicenter cohort study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Diabetes technology and sexual health: which role? JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors REVIEWS IN ENDOCRINE & METABOLIC DISORDERS 2023
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms JOURNAL OF CLINICAL MEDICINE 2023
The Impact of Non-Andrological Medications on Semen Characteristics, Oxidative Stress and Inflammatory Parameters MEDICINA 2023
Necrolytic Migratory Erythema Impact on Prognosis and Diagnosis of Glucagonoma: A Case Report HSOA JOURNAL OF CLINICAL STUDIES & MEDICAL CASE REPORTS 2023
L’intervento metabolico con una dieta a basso contenuto di carboidrati sopprime l’insorgenza e la progressione dei tumori neuroendocrini L'ENDOCRINOLOGO 2023
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Immune Checkpoint Blockade in Lung Carcinoids with Aggressive Behaviour. One More Arrow in Our Quiver? JOURNAL OF CLINICAL MEDICINE 2022

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma